Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
-
- Penson
- Creator
Journal
-
- Lancet
-
Lancet 376 245-,
Details
-
- CRID
- 1370286443560681991
-
- Data Source
-
- Crossref